Human Primary Diabetic Liver Vein Smooth Muscle Cells
Quick Actions
Product Data Sheet
Technical Documentation
Download detailed specifications, protocols, and safety information
File size: 172.6 KB
Product Overview
Description
Human Primary Diabetic Liver Vein Smooth Muscle Cells (SMCs) are critical components of the venous system that supplies and drains the liver, an organ essential for a variety of metabolic processes. These specialized cells line the walls of the liver veins and play a key role in regulating vascular tone, maintaining structural integrity, and controlling blood flow dynamics throughout the hepatic circulation.
Guarantee expansion for a minimum of 2-5 population
doublings.
IMPORTANT: Quality warranty requires use of NeoBioPharma media. Biohazardous material despite negative pathogen testing. Quality claims must be reported within 1 month.
Key Features
Catalog Number: NBPDS008
Product Format: Frozen
Vial Cell Number: > 5x10[5] cells/vial
Passage:1(P1)
Storage: Liquid Nitrogen, Vapor Phase
Intended Use: Research use only (RUO)
Characterization Markers
Characterized by positive expression of smooth muscle cell-specific alpha-actin.
Quick Facts
Product Type
Human Type II Diabetes Endothelial Cells
Viability
>95% viable (Trypan Blue exclusion)
Applications
Metabolic Disease Research: Investigating the mol…
Availability
In Stock • Global Shipping
Technical Specifications
Primary Applications
Applications & Use Cases
Primary Applications
Metabolic Disease Research: Investigating the molecular mechanisms of diabetic vasculopathy. Drug Development: Screening for compounds that protect the vasculature or reverse diabetic damage. Gene Expression Studies: Analyzing how diabetic conditions alter RNA and protein expression compared to healthy cells. Glycation Studies: Studying the effects of Advanced Glycation End-products (AGEs) on vascular smooth muscle function.
Suitable for metabolic disease research: investigating the molecular mechanisms of diabetic vasculopathy. drug development: screening for compounds that protect the vasculature or reverse diabetic damage. gene expression studies: analyzing how diabetic conditions alter rna and protein expression compared to healthy cells. glycation studies: studying the effects of advanced glycation end-products (ages) on vascular smooth muscle function. studies and research applications
Research Areas
In Vitro Studies
Cell culture and screening applications
Molecular Biology
Gene expression & signaling studies
Drug Discovery
Screening & validation studies
Disease Modeling
Pathophysiology research
Support & Resources
Technical Support
Our experts are available for technical questions and protocol assistance.
Contact Support
